|
gptkbp:instanceOf
|
gptkb:insulin
|
|
gptkbp:approvalYear
|
2017
|
|
gptkbp:approvedBy
|
gptkb:FDA
|
|
gptkbp:ATCCode
|
A10AB05
|
|
gptkbp:availableOn
|
gptkb:cartoonist
cartridge
vial
|
|
gptkbp:brand
|
gptkb:insulin
|
|
gptkbp:containsExcipient
|
gptkb:L-arginine
zinc
phenol
glycerol
niacinamide
water for injection
|
|
gptkbp:contraindication
|
hypersensitivity to insulin aspart or excipients
|
|
gptkbp:differenceFromNovolog
|
contains niacinamide for faster absorption
|
|
gptkbp:duration
|
3-5 hours
|
|
gptkbp:form
|
solution for injection
|
|
gptkbp:halfLife
|
~1 hour
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Fiasp
|
|
gptkbp:indication
|
gptkb:type_2_diabetes
type 1 diabetes
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:manufacturer
|
gptkb:Novo_Nordisk
|
|
gptkbp:marketedIn
|
gptkb:Australia
gptkb:Canada
gptkb:European_Union
gptkb:United_States
|
|
gptkbp:mechanismOfAction
|
lowers blood glucose by facilitating cellular uptake of glucose
|
|
gptkbp:onset
|
fast-acting
|
|
gptkbp:pregnancyCategory
|
B (US)
|
|
gptkbp:prescribes
|
adults
children (age 2 and above)
|
|
gptkbp:prescriptionRequired
|
yes
|
|
gptkbp:routeOfAdministration
|
subcutaneous injection
intravenous injection
|
|
gptkbp:sideEffect
|
gptkb:hypoglycemia
injection site reaction
allergic reaction
|
|
gptkbp:storage
|
2-8°C (refrigerated)
|
|
gptkbp:timeToPeak
|
~0.5-1.5 hours
|
|
gptkbp:usedFor
|
gptkb:diabetes_mellitus
|
|
gptkbp:website
|
https://www.fiasp.com/
|
|
gptkbp:bfsParent
|
gptkb:insulin
|
|
gptkbp:bfsLayer
|
6
|